About the Journal

Focus and Scope

Proceedings of Anticancer Research (PAR) is an international peer-reviewed and open access journal, which is devoted to the rapid publication of high-quality original articles, reviews, case reports, short communication and letters on all aspects of experimental and clinical oncology. The covered topics include, but are not limited to: cellular research and bio-markers, identification of bio-targets and agents with novel mechanisms of action, preventative and integrated treatments for cancer patients, radiation and surgery, palliative care, patient adherence, quality of life, satisfaction, and anticancer medicine.

Peer Review Process

All the manuscripts submitted to the Proceedings of Anticancer Research (PAR) will need to go through the following procedure:

The manuscripts will be pre-screened by the in-house editors to ensure adherence to the journal policies.
If a manuscript is deemed suitable for publication in the journal, the Editorial Office will proceed to arrange the manuscript for peer review. The reviewers will be selected from the Editorial Board or other external scholars or researchers. A double-blind peer review procedure is applied to all manuscripts of relevant article types.
A review report including the Editorial Decision (Accept, Minor Revision, Major Revision or Reject) made on the advice of the Editor-in-Chief will be prepared and sent to the authors following the peer review process.
The author is required to address the comments and inquiries in the review report if the Editorial Decision is Minor Revision or Major Revision. In general, the authors should revise and resubmit the paper within 7 days and 14 days upon receipt of the review report if the Editorial Decision is Minor Revision and Major Revision, respectively.
Same procedure is applied to the revised paper.

Authors may appeal for a rejected submission. All appeal requests must be made in writing to editorial@innoscience.org with detailed reasons for the appeal, and point by point responses to the review comments. Decisions on the appeals are final.

The peer-review process is completed once the paper is accepted for publication. The paper will then be arranged for article production which encompasses copy-editing, typesetting and proofreading prior to online publication.

Note: The authors may suggest up to four reviewers from the academic background. The field of the subject matter as described in the submission should match with the research field of the suggested reviewers. The list of the suggested reviewers and their details such as full name, affiliation, email address, etc. should be included in the cover letter which should be submitted during the manuscript submission stage. However, whether or not the suggested reviewers should be recruited to review the manuscript is at the editorial office’s discretion, and the editorial office has the authority to select new reviewers.

Open Access Policy

Proceedings of Anticancer Research (PAR) provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Publishing Ethics

Proceedings of Anticancer Research (PAR) requests all members involved in the journal publishing process to adhere to the Core Practices on publication ethics as stipulated by Committee on Publication Ethics (COPE) in compliance with the information and guidelines on handling publishing ethics allegations as described in the Publishing Ethics Resource Kit (PERK).

The journal editors take all possible misconduct seriously. The Editors, authors or readers can forward their concerns to the journal if they find out that the description in a submitted article may constitute an academic fraud, research misconduct or publication malpractice. The concerns or complaints on the possible allegations submitted to the journal will be dealt with promptly and appropriately according to the procedure set out in the COPE flowchart on complaints and in PERK. The complainant may direct all inquiries and correspondence to the Publisher at info@bbwpublisher.com.

Editorial Policies

Authors should read the Author Guidelines before making a submission, and make sure that the manuscripts were written in accordance to the style and specifications of the journal’s policy.

All manuscripts submitted to Proceedings of Anticancer Research (PAR) are subject to rigorous peer review. Prior to peer review process, the manuscripts will be screened for acceptable English language, novelty and relevance to the Focus and Scope of the journal.

Any manuscripts submitted to Proceedings of Anticancer Research (PAR) will be treated as confidential materials. The manuscripts will not be disclosed to anyone except individuals such as editorial staff, reviewers and editors who participate in the initial screening, peer review, processing and preparation of the manuscript for publication (if accepted).

Acknowledgments

The Acknowledgments section in a paper serves to indicate the individuals, agencies and/or institutions whose contributions merit acknowledgment, rather than authorship. The roles that merit acknowledgment include the acquisition of funding, general supervision of a research group or general administrative support, writing assistance such as technical editing and language editing, as well as proofreading.

The authors should also acknowledge technical assistance involved in the experiments and field trips, as well as assistance in non-technical form such as intellectual discussions.

The authors are also required to declare what financial support they obtained to perform their research. Thus, the authors should acknowledge the funders and mention the roles of the funders in the research as well as the research grant information, e.g. the grant number, in this section.

Conflict of Interest

The authors are required to provide the authorization of no conflict with any financial body or funding agency that might influence the results or interpretation of their manuscripts. All authors, members, reviewers and editors must disclose any association that poses a conflict of interest in connection with the manuscript.

A manuscript would not be accepted if it has been published or is currently under consideration for publication in any other journals. The authors are required to notify the editorial team if the findings and data in their submissions have been presented in conferences.

Author Proofreading

The Editorial Office will send a galley proof to the authors for proofreading at least one week after a manuscript has been accepted. The authors are responsible to read and check the entire proof, and inform the Editorial Office if some mistakes need to be corrected. In general, only minor mistakes will appear in the galley proof, such as typographical errors, layout issue, etc. Significant changes that can affect the scientific integrity and interpretation of findings in the accepted manuscript can be made during the proofreading stage.

Corrections and Additions to Published Papers

The authors are not allowed to make corrections, including addition and deletion of contents in papers after they have already been published.

A corrigendum or an addendum is published at the sole discretion of the editors.

Advertising Policy

All advertisements are subject to approval by the Bio-Byword Scientific Publishing. The advertisements must comply with the relevant regulations in the country where the advertisements appear. Contact the Editorial Office (info@bbwpublisher.com) for more information.

Data Processing Policy

The authors are required to clearly state in the figure legend and in the Methodology section or its equivalent, if alterations (e.g. brightness, contrast, color balance) have been applied to the images.

The Editorial Office reserves the right to request the original data, e.g. raw data and images, from the authors if inappropriate manipulation of data is suspected after paper publication. The suspected paper will be retracted in accordance with the standard guidelines if the claim of data manipulation is proven to be true.

Article Processing Charge

The authors are required to pay the Article Processing Charge (APC) for publishing with Proceedings of Anticancer Research (PAR) to cover the cost incurred in processing the manuscripts in order to ensure the contents are freely available and to maintain publishing quality. The manuscript processing includes peer review, copy-editing, typesetting, publishing, content depositing and archiving processes. An invoice of APC will be issued after a paper has been accepted, where authors are advised to pay the APC within one week to avoid delay in publication.

The APC for processing each article is AUD 600.

Copyright and License

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

License

Proceedings of Anticancer Research publishes accepted manuscripts under Creative Commons Attribution 4.0 International License (CC BY 4.0). Authors who submit their papers for publication in CAS Medicine agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part thereof free of charge for any purpose, including commercial use. As long as the author and original source is properly cited, anyone may copy, redistribute, reuse and transform the content.

Reuse of article content

Anyone is free to reuse Proceedings of Anticancer Research article content licensed under CC BY 4.0 provided that proper attribution is given through citation of the original source.